Callan JMB Inc(CJMB) - 2025 Q1 - Quarterly Report
2025-05-15 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-42506 CALLAN JMB INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S ...
HCW Biologics(HCWB) - 2025 Q1 - Quarterly Report
2025-05-15 21:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40591 HCW Biologics Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 82-5024477 (State or other jurisdictio ...
Callan JMB Inc(CJMB) - 2025 Q1 - Quarterly Results
2025-05-15 21:05
Exhibit 99.1 Business Highlights to Date: ● On February 6, 2025, completed IPO at $4.00 per share with gross proceeds of approximately $5.7 million, including partial exercise of over-allotment. ● Announced the appointment of former Assistant Commissioner of the Chicago Department of Public Health, Christopher Shields, as Senior Vice President, Emergency Preparedness & Response/Government Affairs. ● Requested by the State of Texas Department of Health and Human Services to be on standby in readiness to assi ...
Translational Development Acquisition Corp-A(TDAC) - 2025 Q1 - Quarterly Report
2025-05-15 21:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-42451 TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Island ...
Translational Development Acquisition Corp.(TDACU) - 2025 Q1 - Quarterly Report
2025-05-15 21:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-42451 TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Island ...
Reading International(RDIB) - 2025 Q1 - Quarterly Report
2025-05-15 21:04
Financial Performance - Total revenue for Q1 2025 was $40.169 million, a decrease of 10.4% from $45.052 million in Q1 2024[10] - Net loss attributable to Reading International, Inc. for Q1 2025 was $4.752 million, compared to a net loss of $13.228 million in Q1 2024, representing a 64.1% improvement[10] - Operating income for Q1 2025 was a loss of $6.891 million, slightly improved from a loss of $7.531 million in Q1 2024[10] - The company reported a comprehensive loss of $4.301 million for Q1 2025, compared to a comprehensive loss of $15.768 million in Q1 2024, indicating a significant reduction in losses[12] - Total revenue for the three months ended March 31, 2025, was $4,845,000, a decrease of 1.8% compared to $4,933,000 for the same period in 2024[40] - The company reported a net loss attributable to Reading International, Inc. of $4,752,000 for the three months ended March 31, 2025, compared to a net loss of $13,228,000 in the same period of 2024[46] - Basic and diluted earnings per share for Q1 2025 were both $(0.21), an improvement from $(0.59) in Q1 2024[46] Assets and Liabilities - Cash and cash equivalents decreased to $5.911 million as of March 31, 2025, down from $12.347 million at the end of 2024[9] - Total assets decreased to $440.969 million as of March 31, 2025, from $471.011 million at the end of 2024, a decline of 6.4%[9] - Total liabilities decreased to $449.649 million as of March 31, 2025, down from $475.801 million at the end of 2024, a reduction of 5.5%[9] - The company has $53.7 million of debt due within the next twelve months, with a negative working capital of $108.7 million[18] - Total borrowings as of March 31, 2025, amounted to $186.6 million, down from $201.8 million as of December 31, 2024[71] - The current portion of debt decreased to $53.7 million as of March 31, 2025, from $69.2 million as of December 31, 2024[76] - The company's debt-to-equity ratio was (21.50) as of March 31, 2025, indicating a significant increase in leverage compared to (42.32) in 2024[200] - Working capital deficit was reported at $108.7 million as of March 31, 2025, worsening from a deficit of $104.6 million in 2024[200] Cash Flow and Financing Activities - Cash used in operating activities increased by $4.9 million to $7.7 million in Q1 2025, compared to $2.8 million in Q1 2024[197] - Cash provided by investing activities was $17.9 million in Q1 2025, significantly higher than $7.6 million in Q1 2024, due to proceeds from the sale of Wellington property assets[198] - Cash used in financing activities increased by $5.6 million to $16.9 million in Q1 2025, compared to the same period in 2024, driven by higher loan paydowns[199] - The company sold its Wellington property assets for NZ$38.0 million in January 2025, using proceeds to repay loans[192] Real Estate and Asset Management - The company intends to raise liquidity through real estate asset monetization, having successfully sold eight property assets since 2021[22] - The company is under an unconditional contract to sell its Cannon Park property for AU$32.0 million, expected to close on May 21, 2025[21] - The company has monetized several property assets to improve liquidity, including the sale of its Courtenay Central cinema with a long-term leaseback agreement[161] - The company has paused real estate development projects to bolster liquidity, focusing on improvements to existing cinemas instead[136] - The company has entered into an agreement to lease a newly redeveloped 10-screen cinema in Wellington, New Zealand, following the sale of its properties in the region for NZ$38.0 million[168] Cinema Operations - The cinema exhibition segment generated $36.4 million in revenue for the three months ended March 31, 2025, down from $41.3 million in the same period in 2024[37] - The total operating expense for the cinema segment was $40.9 million for the three months ended March 31, 2025, compared to $45.4 million in the same period in 2024[37] - The company recorded a segment operating loss of $4.5 million in the cinema segment for the three months ended March 31, 2025, compared to a loss of $4.2 million in the same period in 2024[37] - The cinema business performance in Q1 2025 was weaker than anticipated, with notable films underperforming compared to industry expectations[121] - The cinema segment operating loss increased by $0.3 million to $4.5 million, attributed to decreased revenue from lower attendance[181] - The cinema segment is expected to benefit from a strong film lineup in 2025, including titles like Lilo & Stitch and Mission Impossible – The Final Reckoning[129] Cost Management and Efficiency - The company has been renegotiating leases to reduce occupancy costs or convert fixed rent to percentage rent, aligning interests with landlords[124] - The company reduced future insurance costs by approximately $1.3 million for the remainder of 2025 through renegotiated supplier contracts[125] - Total operating expenses decreased to $1,955,000 for the three months ended March 31, 2025, down 12.5% from $2,235,000 in the prior year[40] - Depreciation, amortization, and general administrative expenses decreased by 28% to $1.3 million in Q1 2025, compared to $1.8 million in Q1 2024[185] Legal and Regulatory Matters - The company has accrued estimates of probable and estimable losses related to ongoing legal proceedings, although it does not expect these to have a material adverse effect on its business[92] - The company does not currently believe that its exposure under applicable environmental laws is material in amount, despite historical involvement in operations that may have environmental implications[93] Market Conditions and Future Outlook - Management believes that improvements in film releases will enhance patronage and operating revenue, although attendance levels remain uncertain[20] - The company is optimistic about the cinema industry's long-term prospects, citing upcoming high-quality film releases and strong audience attendance for select films[123]
Reading International(RDI) - 2025 Q1 - Quarterly Report
2025-05-15 21:04
Financial Performance - Total revenue for Q1 2025 was $40.169 million, a decrease of 10.4% from $45.052 million in Q1 2024[10] - Net loss attributable to Reading International, Inc. for Q1 2025 was $4.752 million, compared to a net loss of $13.228 million in Q1 2024, representing a 64.1% improvement[10] - Operating income for Q1 2025 was a loss of $6.891 million, slightly improved from a loss of $7.531 million in Q1 2024[10] - The company reported a comprehensive loss of $4.301 million for Q1 2025, compared to a comprehensive loss of $15.768 million in Q1 2024, indicating a significant reduction in losses[12] - Total segment revenue was $41.249 million, down from $46.204 million in the same period of 2024, reflecting a decrease of approximately 10.5%[37] - The cinema exhibition segment reported a revenue of $36.404 million for the three months ended March 31, 2025, compared to $41.271 million for the same period in 2024, a decline of about 12%[39] - Total revenue for the quarter ended March 31, 2025, decreased by $4.9 million to $40.2 million, a decline of 11% compared to the same period in 2024[174] - Cinema exhibition revenue dropped by $4.9 million to $36.4 million, a decrease of 12% year-over-year, primarily due to lower attendance and cinema closures[180] Assets and Liabilities - Cash and cash equivalents decreased to $5.911 million as of March 31, 2025, down from $12.347 million at the end of 2024[9] - Total assets decreased to $440.969 million as of March 31, 2025, from $471.011 million at the end of 2024, a decline of 6.4%[9] - Total liabilities decreased to $449.649 million as of March 31, 2025, down from $475.801 million at the end of 2024, a reduction of 5.5%[9] - The company has $53.7 million of debt due within the next twelve months, with a negative working capital of $108.7 million[18] - Total borrowings as of March 31, 2025, amounted to $186.6 million, down from $201.8 million as of December 31, 2024[76] - The current portion of debt decreased to $53.7 million as of March 31, 2025, from $69.2 million as of December 31, 2024[76] - The company's debt-to-equity ratio was (21.50) as of March 31, 2025, a significant increase from (42.32) in 2024[200] - Working capital deficit was reported at $108.7 million as of March 31, 2025, compared to $104.6 million in 2024[200] Cash Flow and Financing Activities - Cash used in operating activities increased by $4.9 million to $7.7 million in Q1 2025, compared to $2.8 million in Q1 2024[197] - Cash provided by investing activities was $17.9 million in Q1 2025, significantly higher than $7.6 million in Q1 2024, due to proceeds from the sale of Wellington property assets[198] - Cash used in financing activities increased by $5.6 million to $16.9 million in Q1 2025, compared to the same period in 2024, driven by higher loan paydowns[199] - The company has $53.7 million in debt coming due in the next 12 months, with ongoing efforts to manage liquidity and defer capital expenditures[191] Real Estate and Asset Management - The company intends to raise liquidity through real estate asset monetization, having successfully sold eight property assets since 2021[22] - The company is under an unconditional contract to sell its Cannon Park property for AU$32.0 million, expected to close on May 21, 2025[21] - The company monetized its properties in Wellington, New Zealand for $21.5 million in Q1 2025, contributing to liquidity[51] - The gain on the sale of the Wellington property was $6,566,000 after direct costs[54] - The company sold its Wellington property assets for NZ$38.0 million in January 2025, using proceeds to repay loans[192] - The company has paused real estate development projects to bolster liquidity, focusing on improvements to existing cinemas instead[136] Operating Expenses and Cost Management - Total operating expenses decreased to $1,955,000 in Q1 2025 from $2,235,000 in Q1 2024, reflecting a reduction of 12.5%[40] - The total operating expense for the cinema segment was $40.879 million for the three months ended March 31, 2025, compared to $45.436 million in the same period of 2024, a decrease of approximately 10.5%[37] - Operating expenses for the quarter decreased by $4.2 million to $37.7 million, reflecting lower costs across all regions[182] - The cinema segment operating loss increased by $0.3 million to $4.5 million, driven by decreased revenue from lower attendance[181] Strategic Initiatives and Future Outlook - The management believes that improvements in film releases will enhance patronage and operating revenue, although attendance levels remain uncertain[20] - The cinema industry is expected to benefit from a strong movie release schedule from 2025 to 2027, including high-quality films like Superman and Jurassic World: Rebirth[123] - The cinema segment is expected to benefit from notable movie releases in 2025, including "Mission: Impossible – The Final Reckoning" and "Avatar: Fire and Ash" which are anticipated to drive audience attendance[129] - The company is actively pursuing liquor licenses to enhance Food and Beverage offerings across its cinema circuits in the U.S., Australia, and New Zealand[133] Stock and Equity - Basic and diluted earnings per share for Q1 2025 were both $(0.21), compared to $(0.59) in Q1 2024[46] - The company’s total stockholders' equity decreased from $(4,790,000) at January 1, 2025, to $(8,680,000) at March 31, 2025[97] - The company has accrued estimates of probable and estimable losses related to ongoing legal proceedings, although it does not expect these to have a material adverse effect on its business[92] Miscellaneous - The average exchange rate for the Australian Dollar was 0.6277 for the quarter ended March 31, 2025, compared to 0.6524 for the same quarter in 2024, indicating a strengthening of the USD[44] - The company recorded no impairment charges for the first three months of 2025, despite lower revenues and operating income compared to the same period in 2024[25] - The company has liquor licenses in 100% of its U.S. cinemas, 86% in Australia, and 38% in New Zealand, with ongoing efforts to increase licensing in New Zealand[158]
Nuvve (NVVE) - 2025 Q1 - Quarterly Report
2025-05-15 21:04
Financial Performance - Total revenue for the three months ended March 31, 2025, was $934,304, an increase of 20% compared to $779,756 for the same period in 2024[199]. - Products revenue increased by 19% to $565,551, while services revenue rose by 22% to $267,304, and grants increased by 22% to $101,449[199]. - Operating loss decreased by 23% to $5,586,614 for the three months ended March 31, 2025, compared to $7,247,375 for the same period in 2024[199]. - Net loss for the three months ended March 31, 2025, was $6,878,601, a 2% increase from $6,728,737 in the same period in 2024[199]. Expenses - Research and development expenses decreased by 44% to $883,772 for the three months ended March 31, 2025, down from $1,589,577 in the prior year[205]. - Selling, general and administrative expenses decreased by 14% to $5,075,902 for the three months ended March 31, 2025, compared to $5,928,110 in 2024[203]. Cash Flow and Debt - The cash used in operations was $1.8 million for the three months ended March 31, 2025, compared to $15.7 million and $21.3 million for the years ended December 31, 2024, and 2023, respectively[212]. - Net cash used in operating activities decreased by $2.9 million to $1.8 million for the three months ended March 31, 2025, compared to $4.7 million for the same period in 2024[225]. - Net cash provided for financing activities was $2.6 million for the three months ended March 31, 2025, compared to $8.5 million for the same period in 2024[227]. - The total outstanding principal balance of debt as of March 31, 2025, was $4,967,360, down from $5,572,001 as of December 31, 2024[218]. - The company entered into Term Loans totaling $3.75 million with a weighted average interest rate of 2.96% and 2.16% for different maturities[216]. - Interest expense paid on the Term Loan for the three months ended March 31, 2025, was $363,042, with no interest expense for the same period in 2024[216]. Future Outlook - Estimated backlog as of March 31, 2025, was $19.7 million, expected to be recognized as revenue from 2025 through 2026[195]. - The company plans to allocate up to 30% of excess cash towards bitcoin purchases as part of its treasury management program[196]. - The company expects to implement its bitcoin and digital asset strategy in the latter half of 2025[197]. - The company plans to fund current operations through debt obligations, increased revenues, and raising additional capital, although future fundraising success is uncertain[213]. Legal Matters - The company has initiated legal action against Rhombus Energy Solutions, Inc. regarding warranty and commissioning obligations related to DC Chargers purchased[223]. Equity and Financial Position - The company had a total equity deficit of $3.2 million and a cash balance of $1.2 million as of March 31, 2025[212]. - As of March 31, 2025, the company incurred operating losses of approximately $5.6 million for the three months ended March 31, 2025, and $20.5 million and $32.1 million for the years ended December 31, 2024, and 2023, respectively[212].
T Stamp (IDAI) - 2025 Q1 - Quarterly Report
2025-05-15 21:04
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _____________ Commission file number: 001-41252 T Stamp Inc. (D/B/A Trust Stamp) (Exact name of registrant as specified in its charter) ...
byNordic Acquisition (BYNO) - 2025 Q1 - Quarterly Report
2025-05-15 21:04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41273 BYNORDIC ACQUISITION CORPORATION (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) Delaware 84-4529 ...